The bear market knocked down growth stocks by the dozens last year -- even if these companies didn't report bad news. So, if a particular growth company actually did report disappointing news, losses were much greater. And that's what happened to Teladoc Health (NYSE: TDOC) and Novavax (NASDAQ: NVAX).

Teladoc reported two significant impairment charges. And Novavax's coronavirus vaccine authorization came later than expected. The companies may be heading for better days, though. And that's why these growth players could go parabolic.

Teladoc stock sank 74% last year after the company reported two noncash goodwill impairment charges. These implied the telemedicine giant paid too much when it acquired Livongo back in 2020.

Continue reading

Source Fool.com